- February 25, 2024
Lucky Loop Medical AB
Lucky Loop Medical AB aims to improve the diagnosis of all cystic lesions. However, pancreatic cancer has the lowest five-year survival among all cancers and is estimated to be the second deadliest by 2030, making pancreatic cysts our the company’s priority. With a core team of PhDs in medical engineering and gastroenterology, Lucky Loop Medical develops the world’s smallest brush for minimally invasive diagnosis of pancreatic cysts during endoscopic-guided fine needle aspiration. With an easily transferable technology to the operating room, the company team aims to directly affect 14% of pancreatic cancers and the diagnosis of 4 million potentially cancerous cysts worldwide.
Lucky Loop Medical’s founders include MedTechLabs researcher Niclas Roxhed.